ArticleCureus2026

Obinutuzumab Treatment in Rituximab- and Bortezomib-Resistant Phospholipase A2 Receptor Antibody-Positive Membranous Nephropathy.

Uygar Yildirim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.